0.34%| Prev Close: | 98.45 |
|---|---|
| Open: | 98.83 |
| Bid: | 98.10 x 200 |
| Ask: | 99.09 x 200 |
| 1y Target Est: | 113.54 |
| Beta: | 0.64 |
| Next Earnings Date: | N/A |
| Day's Range: | 97.86 - 99.65 |
|---|---|
| 52wk Range: | 81.28 - 116.45 |
| Volume: | 3,799,979 |
| Avg Vol (3m): | 1,804,190 |
| Market Cap: | 29.21B |
| P/E (ttm): | 34.22 |
| EPS (ttm): | 2.88 |
| Div & Yield: | 0.20 (0.20%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGNat TheStreet(Mon, May 20)
- Allergan Stock To Go Ex-dividend Tomorrow (AGN)at TheStreet(Mon, May 20)
- Allergan About To Put More Money In Your Pocket (AGN)at Forbes(Fri, May 17)
- Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care InnovationWall Street Transcript(Thu, May 16)
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downwardat TheStreet(Thu, May 16)
- Why This Stock's Crash is a Buying Opportunityat Motley Fool(Tue, May 14)
- ALLERGAN INC FinancialsEDGAR Online Financials(Sat, May 11)
- New Stock Coverage: Frozen Smiles All Around at Allerganat Minyanville(Fri, May 10)
- Should We Get Bullish on This Fast Growing Healthcare Company?at Motley Fool(Fri, May 10)
- Obesity Surgery in India Spurs J&J Stomach-Staple Salesat Bloomberg(Thu, May 9)
- Allergan Inc. (AGN): Today's Featured Drugs Laggardat TheStreet(Wed, May 8)
- The Next Billionaire: A Statistician Who Changed Medicineat Forbes(Wed, May 8)
- [video] 'Mad Money' Uncovered: Allerganat TheStreet(Wed, May 8)
- Gastric banding: Pros and cons of Christie's surprising choiceat Reuters(Tue, May 7)
- What Gov. Christie's Secret Weight-Loss Surgery Means for Investorsat Motley Fool(Tue, May 7)
Press Releases
- FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-FaceBusiness Wire(Thu, May 2)
- Allergan Reports First Quarter 2013 Operating ResultsBusiness Wire(Wed, May 1)
- Allergan Announces Death of Stephen J. Ryan, M.D.Business Wire(Tue, Apr 30)
Reports
- AGN: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 21)
- Thomson Reuters Stock Report - ALLERGAN, INC. (AGN-N)Thomson Reuters Stock Report(May 21)
- ValuEngine Industry Report for Large CAP PharmaValuEngine, Inc.(May 21)